113 filings
Page 4 of 6
8-K
vo549q 8j866
2 Jul 20
Entry into a Material Definitive Agreement
5:09pm
8-K
edmt53wx2r8el
2 Jun 20
Regulation FD Disclosure
8:00am
8-K
ewjs 19h6
11 May 20
Matinas BioPharma Reports First Quarter 2020 Financial Results and Operational Highlights
5:18pm
8-K
vw6t9 k3i3ubv1
9 Mar 20
Matinas BioPharma Reports Fourth Quarter and Full Year 2019
4:28pm
8-K
n9238l7spueo6lx2
20 Feb 20
Termination of a Material Definitive Agreement
6:01am
8-K
ud6xw3pq34x5na x1r
10 Jan 20
Matinas BioPharma Announces Proposed Public Offering of Common Stock
4:50pm
8-K
nvezn4iz ylruv
1 Nov 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
7g5qevo y04iy6618oc
13 Aug 19
Matinas BioPharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
7:00am
8-K
25ovxj
14 May 19
Matinas BioPharma Provides Corporate Update and Reports First Quarter 2019 Financial Results
7:05am
8-K
bynjkp 9xwh4c67cjb
2 Apr 19
Matinas BioPharma Reports 2018 Financial Results and Provides Corporate Update
7:20am
8-K
sv04nss
15 Mar 19
Matinas BioPharma Announces Proposed Public Offering of Common Stock
5:15pm
8-K
zcwfsy5q1 is
25 Feb 19
Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer
8:15am
8-K
iv9mnj vt
3 Jan 19
Matinas BioPharma Appoints Keith A. Kucinski, CPA, MBA as Chief Financial Officer
8:05am
8-K
ag9cvlhpp79v17h0rix
2 Nov 18
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
czdapq hdt
15 Oct 18
Departure of Directors or Certain Officers
8:00am
8-K
upoln1ch1yae mf87w
6 Sep 18
Matinas BioPharma Announces Appointment of Industry Leader Patrick G. LePore to Board of Directors
12:00am
8-K
eubijebwfy 6txs5
19 Jun 18
Matinas BioPharma Announces Pricing of $8.0 Million Public Offering
5:19pm
8-K
3aq jfulayn66
18 Jun 18
Departure of Directors or Certain Officers
5:23pm
8-K
535rc9ojsh
25 May 18
Other Events
11:17am
8-K
8xhihay71dtyu
27 Mar 18
Departure of Directors or Certain Officers
12:00am